Current studies focusing on specially designed small protein chains, a unique category of molecules showing significant promise for targeting different condition mechanisms. Compared to traditional drug approaches, Nexaph peptides offer enhanced specificity and lesser off-target effects, enabling them a truly attractive pathway for next-generation